AI-powered search
Try Polaris, our new AI-powered search!

Do you need to monitor any laboratory testing with topical JAK inhibitors?

Featuring James Del Rosso, DO | Clinical Advisor |

Adjunct Clinical Professor, Dermatology
Touro University Nevada
Henderson, NV

| Published August 18, 2021

More from this series

Who is a good candidate for lebrikizumab?

Atopic Dermatitis

Who is a good candidate for lebrikizumab?

Featuring Raj Chovatiya, MD, PhD, MSCI

What is the dosing regimen for lebrikizumab?

Atopic Dermatitis

What is the dosing regimen for lebrikizumab?

Featuring Raj Chovatiya, MD, PhD, MSCI

What is the safety profile of lebrikizumab?

Atopic Dermatitis

What is the safety profile of lebrikizumab?

Featuring Raj Chovatiya, MD, PhD, MSCI

Related Media

Powered by Polaris TM